G. Vanhove

发表

Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system

M. Versavel, K. Patel, D. Amtmann, 2016, Pain.

Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations.

Richard E. White, Christopher L. Wu, E. Kalso, 2016, Pain.

Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations.

James N. Campbell, M. Rowbotham, R. Freeman, 2019, The journal of pain : official journal of the American Pain Society.

Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-Concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain

K. Bley, M. Mouksassi, J. Marier, 2009, Therapeutic drug monitoring.

Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia

L. Webster, J. Tobias, M. Nunez, 2011, BMC anesthesiology.

Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations

M. Rowbotham, R. Freeman, K. Patel, 2022, The journal of pain.

Robust Colonic Epithelial Regeneration and Amelioration of Colitis via FZD-Specific Activation of Wnt Signaling

W. Yeh, Linfu Xie, H. Baribault, 2022, Cellular and molecular gastroenterology and hepatology.

Long-term Safety of Gastroretentive Gabapentin in Postherpetic Neuralgia Patients

M. Jensen, M. Wallace, R. Rauck, 2013, The Clinical journal of pain.

Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).

M. Saulino, T. Deer, M. Wallace, 2020, Pain medicine.

Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)

M. Saulino, T. Deer, M. Wallace, 2018, Pain Practice.

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.

J. Tobias, M. Backonja, T. Malan, 2010, Pain medicine.

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy

T. Blaschke, L. Sheiner, K. Squires, 1997, Antimicrobial agents and chemotherapy.

Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy

L B Sheiner, T F Blaschke, D Verotta, 1997, Antimicrobial agents and chemotherapy.

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

D. Simpson, L. Webster, J. Tobias, 2011, Journal of pain research.

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials

G. Schifitto, D. Simpson, B. Brew, 2013, AIDS Research and Therapy.

A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy

D. Clifford, B. Conway, D. Simpson, 2012, Journal of acquired immune deficiency syndromes.

Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain

L. Webster, J. Tobias, J. Peppin, 2012, Journal of pain research.

A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers.

K. Bley, D. Simone, G. Wendelschafer‐Crabb, 2010, The journal of pain : official journal of the American Pain Society.

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.

D. Simpson, L. Webster, J. Tobias, 2010, Journal of pain and symptom management.

NGX-4010 , a Capsaicin 8 % Dermal Patch , Administered Alone or in Combination With Systemic Neuropathic Pain Medications , Reduces Pain in Patients With Postherpetic Neuralgia

L. Webster, J. Tobias, M. Backonja, 2011 .

Evaluation of composite responder outcomes of pain intensity and physical function in neuropathic pain clinical trials: an ACTTION individual patient data analysis

M. Rowbotham, K. Patel, J. Farrar, 2018, Pain.

Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.

L. Webster, J. Tobias, J. Peppin, 2011, Diabetes research and clinical practice.

A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

J. Tobias, M. Backonja, E. Blonsky, 2011, Pain medicine.

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.

L. Webster, J. Tobias, T. Malan, 2010, The journal of pain : official journal of the American Pain Society.

Safety and efficacy of NGX-4010, a prescription strength capsaicin 8% patch, for the management of postherpetic neuralgia (PHN) in the older population

L. Webster, J. Tobias, M. Backonja, 2011 .

Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia.

M. Jensen, P. Hsu, G. Vanhove, 2012, Pain medicine.

NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-associated Distal Sensory Polyneuropathy: Results of a 52-Week Open-Label Study

D. Simpson, J. Tobias, G. Vanhove, 2013, The Clinical journal of pain.

Patient compliance and drug failure in protease inhibitor monotherapy.

T F Blaschke, T. Merigan, J. Schapiro, 1996, JAMA.

Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.

M. Wallace, R. Rauck, M. Sweeney, 2013, Journal of pain and symptom management.

(393) Effect of concomitant antidepressant and anticonvulsant use on adverse events in patients receiving intrathecal ziconotide in a long-term extension study

L. Webster, M. Wallace, R. Rauck, 2014 .

Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia

L. Webster, J. Tobias, R. Rauck, 2010, BMC neurology.

NEUROPATHIC PAIN SECTION Original Research Articles A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia

J. Tobias, M. Backonja, E. Blonsky, 2011 .

NGX-4010, a Capsaicin 8% Dermal Patch, Administered Alone or in Combination With Systemic Neuropathic Pain Medications, Reduces Pain in Patients With Postherpetic Neuralgia

J. Tobias, G. Vanhove, R. Schwendimann, 2012, The Clinical journal of pain.

Variation in quantitative sensory testing and epidermal nerve fiber density in repeated measurements

J. Hodges, D. Simone, G. Wendelschafer‐Crabb, 2010, PAIN®.